Cloning, expression and initial characterisation of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10)

Genes and Immunity

Volumn 1, Issue 7, 2000, Pages 442-450

  Gallagher, G ^a   Dickensheets, H ^b   Eskdale, J ^a   Izotova, L S ^c   Mirochnitchenko, O V ^c   Peat, J D ^a   Vazquez, N ^b   Pestka, S ^c   Donnelly, R P ^b   Kotenko, S V ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Chromosome one; Cloning; Expression; Homologue; Interleukin 10; Interleukin 19; Monocyte

Indexed keywords

COMPLEMENTARY DNA; IL19 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN DERIVATIVE; MESSENGER RNA; PRIMER DNA;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ARTICLE; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MONOCYTE; NUCLEOTIDE SEQUENCE; SEQUENCE HOMOLOGY;

5' UNTRANSLATED REGIONS; AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; HUMANS; INTERLEUKIN-10; INTERLEUKINS; MOLECULAR SEQUENCE DATA; MONOCYTES; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0034303102     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363714     Document Type: Article

References (63)

1. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165-190.
2. de Waal Malefyt RD, Abrams J, Bennet B, Figdor GC, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220.
3. de Waal Malefyt R, Figdor CG, Huijbens R et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993; 151: 6370-6381.
4. Wanidworanun C, Strober W. Predominant role of tumour necrosis factor-α in human monocyte IL-10 synthesis. J Immunol 1993; 151: 6853-6861.
5. Becker JC, Czerny C. Maintenance of clonal anergy by endogenously produced IL-10. Int Immunol 1994; 6: 1605-1612.
6. Groux H, O'Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-742.
7. Asseman C, Powrie F. Interleukin 10 is a growth factor for a population of regulatory T cells. Gut 1998; 42: 157-158.
8. Hsu DH, de Waal Malefyt R, Fiorentino DF et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990; 250: 830-832.
9. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248: 1230-1234.
10. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 2000; 97: 1695-1700.
11. Itoh K, and Hirohata S. The role of IL-10 in human B-cell activation, proliferation and differentiation. J Immunol 1995; 154: 4341-1350.
12. Perez L, Orte J, Brieva JA. Terminal differentiation of spontaneous rheumatoid factor-secreting B-cells from rheumatoid arthritis patients depends on endogenous interleukin-10. Arthritis Rheum 1995; 38: 1771-1776.
13. Llorente L, Zou W, Levy Y et al. Role of Interleukin-10 in the B-lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181: 839-844.
14. Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between microsatellite alleles at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997; 49: 635-639.
15. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1090-1095.
16. Mehrian R, Quismorio FP Jr, Strassmann G et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 1998; 41: 596-602.
17. Cush JC, Splawski JB, Thomas R et al. Elevated levels of interleukin-10 in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 96-104.
18. Llorente L, Richaud-Patin Y, Fior R et al. In vivo production of Interleukin-10 by non-T-cells in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1647-1655.
19. Eskdale J, McNicholl J, Wordsworth P et al. IL-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 1998; 352: 1282-1283.
20. Matsuda M, Salazar F, Petersson M et al. Interleukin 10 pretreatment protects target cells from tumour-and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 1994; 180: 2371-2376.
21. Luscher U, Filgueira L, Juretic A et al. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumour infiltrating lymphocytes. Int J Cancer 1994; 57: 612-619.
22. Stearns ME, Fudge K, Garcia F et al. IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression. Invasion Metastasis 1997; 17: 62-74.
23. Kundu N, Fulton AM. Interleukin-10 inhibits tumour metastasis, downregulates MHC class I, and enhances NK lysis. Cell Immunol 1997; 180: 55-61.
24. Sun H, Gutierrez P, Jackson MJ, Kundu N, Fulton AM. Essential role of nitric oxide and interferon-gamma for tumour immunotherapy with interleukin-10. J Immunotherapy 2000, 23: 208-214.
25. Nedospasov SA, Shakhov AN, Turetskaya RL et al. Tandem arrangement of genes coding for tumour necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome. Cold Spring Harb Symp Quant Biol 1986; 51: 611-624.
26. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumour necrosis factor family. Cell 1993; 75: 1169-1178.
27. Hahne M, Kataoka T, Schroter M et al. APRIL, a new ligand of the tumour necrosis factor family, stimulates tumour cell growth. J Exp Med 1998; 188: 1185-1190.
28. Li H, Chen J, Huang A et al. Cloning and characterisation of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 2000; 97: 773-778.
29. Zdanov A, Schalk-Hihi C, Gustchina A, Tsang M, Weatherbee J, Wlodawer A. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon-gamma. Structure 1995, 3: 591-601.
30. Zdanov A, Schalk-Hihi C, Wlodawer A. Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor. Protein Sci 1996; 5: 1955-1962.
31. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immun 1999; 17: 19-49.
32. Donnelly RP, Freeman SL, Hayes MP. Inhibition of IL-10 expression by IFN-γ up-regulates transcription of tumour necrosis factor-α in human monocytes. J Immunol 1995; 155: 1420-1427.
33. Kotenko SV, Krause CD, Izotova LS et al. Identification and functional characterisation of a second chain of the interleukin-10 receptor complex. EMBO J 1997; 16: 5894-5903.
34. Kotenko SV, Izotova LS, Pollack BP et al. Interaction between the components of the interferon gamma receptor complex. J Biol Chem 1995; 270: 20915-20921.
35. Kotenko SV, Pestka S. Jak-Stat signal transduction through the eyes of cytokine classII receptor complexes. Oncogene Rev 2000; 19: 2557-2565.
36. Pestka S, Kotenko SV, Muthukumaran G, Izotova LS, Cook JR, Garotta G. The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Growth Factor Rev 1997; 8: 189-206.
37. Walter MR, Windsor WT, Nagabhushan TL et al. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature 1995; 376: 230-235.
38. Ealick SE, Cook WJ, Vijay-Kumar S et al. Three-dimensional structure of recombinant human interferon-gamma. Science 1991; 252: 698-702.
39. Walter MR, Nagabhushan TL. Crystal structure of interleukin 10 reveals an interferon gamma-like fold. Biochemistry 1995; 34: 12118-12125.
40. Ding Y, Qin L, Kotenko SV, Pestka S, Bromberg JS. A single amino acid determines the immunostimulatory activity of interleukin 10. J Exp Med 2000; 191: 213-224.
41. Onu A, Pohl T, Krause H, Bulfone-Paus S. Regulation of IL-15 secretion via the leader sequence of two IL-15 isoforms. J Immunol 1997; 158: 255-262.
42. de Baey A, Fellerhoff B, Maier S, Martinozzi S, Weidle U, Weiss EH. Complex expression pattern of the TNF region LST1 gene through differential regulation initiation and alternative splicing. Genomics 1997; 45: 591-598.
43. Voyle RB, Rathjen PD. Regulated expression of alternative transcripts from the mouse oncostatin-M gene: implications for interleukin-6 family cytokines. Cytokine 2000; 12: 134-141.
44. Mummidi S, Ahuja SS, McDaniel BL, Ahuja SK. The human CC chemokine receptor (CCR5) gene. J Biol Chem 1997; 272: 30662-30671.
45. Kube D, Platzer C, von Knethen A et al. Isolation of the human interleukin 10 promoter. Characterisation of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1995; 7: 1-7.
46. Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1999; 1: 151-155.
47. D'lfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region Genes Immun 2000; 1: 231-234.
48. Kambayashi T, Jacob CO, Strassmann G. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cell Immunol 1996; 171: 153-158.
49. 2. Proc Natl Acad Sci USA 1989; 86: 3803-3807.
50. te Velde AA, Huijbens RJF, Heije K, de Vries JE, Figdor GC. Interleukin-4 (IL-4) inhibits secretion of IL-1β, TNF-α and IL-6 by human monocytes. Blood 1990; 76: 1392-1397.
51. Lehmann MH. Recombinant human granulocyte-macrophage colony-stimulating factor triggers interleukin-10 expression in the monocytic cell line U937. Mol Immunol 1998; 35: 479-485.
52. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151: 4562-4573.
53. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353-356.
54. Dumoutier L, Louahed J, Renauld JC. Cloning and characterisation of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000; 164: 1814-1819.
55. Knappe A, Hor S, Wittmann S, Fickenscher H. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol 2000; 74: 3881-3887.
56. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Annlyt Biochem 1983; 132: 6-13.
57. Wahl LM, Katona IM, Wilder RL et al. Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterisation of B lymphocyte, T lymphocyte and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol 1984; 85: 373-383.
58. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987; 162: 156-159.
59. Soh J, Donnelly RJ, Kotenko SV et al. Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell 1994; 76: 793-802.
60. Goldman LA, Cutrone EC, Kotenko SV, Krause CD, Langer JA. Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques 1996; 21: 1013-1015.
61. Sussman DJ, Milman G. Short-term, high-efficiency expression of transfected DNA. Mol Cell Biol 1984; 4: 1641-1643.
62. Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 1981; 23: 175-182.
63. Aruffo A, Seed B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc Natl Acad Sci USA 1987; 84: 8573-8577.